| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/02/2008 | EP1939166A1 Plants extracts for use in brain modulation |
| 07/02/2008 | EP1938824A1 Medicine, food and drink or feed containing sphingomyelin |
| 07/02/2008 | EP1938814A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| 07/02/2008 | EP1938811A1 Medicinal composition for treating bulimia and depression accompanying bulimia |
| 07/02/2008 | EP1937827A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 07/02/2008 | EP1937721A2 Anit-il-23 antibiodies |
| 07/02/2008 | EP1937699A2 Hypophosphorous acid derivatives and their therapeutical applications |
| 07/02/2008 | EP1937688A1 Imidazo benzodiazepine derivatives |
| 07/02/2008 | EP1937687A1 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5 AMINE |
| 07/02/2008 | EP1937680A2 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 07/02/2008 | EP1937679A2 Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders |
| 07/02/2008 | EP1937677A1 Cb-1 modulating compounds and their use |
| 07/02/2008 | EP1937674A1 Isoxazole derivatives |
| 07/02/2008 | EP1937672A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 07/02/2008 | EP1937670A1 Benzimidazolones which have activity at m1 receptor |
| 07/02/2008 | EP1937668A1 Octahydropentalene-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 07/02/2008 | EP1937659A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | EP1937658A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | EP1937657A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | EP1937653A1 Pyrimidine derivatives and their use as kcnq potassium channels openers |
| 07/02/2008 | EP1937650A1 Heterocyclic compounds |
| 07/02/2008 | EP1937649A1 Imidazole derivatives for the treatment of anxiety and related diseases |
| 07/02/2008 | EP1937286A2 Compositions comprising dimethyl sulfoxide (dmso) |
| 07/02/2008 | EP1937279A2 Use of inhibitors of pi3k-c2a for the treatment of apoptosis-related disorders |
| 07/02/2008 | EP1937268A2 Indenoisoquinolinone analogs and methods of use thereof |
| 07/02/2008 | EP1937265A2 Comination of a hypnotic agent and r(+)-alpha-(2,3-dimethoxy-phenyl)-1-[2-(4-fluorophenl)ethyl]-4-piperidinemethanol and therapeutic application thereof |
| 07/02/2008 | EP1937261A1 Novel azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/02/2008 | EP1937260A2 In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 07/02/2008 | EP1937259A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 07/02/2008 | EP1937252A2 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
| 07/02/2008 | EP1937243A2 Naphthyl derivatives as inhibitors of beta-amyloid aggregation |
| 07/02/2008 | EP1937242A2 Methods and compositions for the treatment of neuropsychiatric and addictive disorders |
| 07/02/2008 | EP1937241A1 Pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder using sodium phenylbutyrate |
| 07/02/2008 | EP1937239A2 Pharmaceutical compositions comprising carboxyalkylsulfonic acids |
| 07/02/2008 | EP1937236A2 Modulation of neurogenesis by hdac inhibition |
| 07/02/2008 | EP1778623B1 Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases |
| 07/02/2008 | EP1646626B1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 07/02/2008 | EP1646625B1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 07/02/2008 | EP1572698B1 3-substituted 3,4-dihydro-thieno¬2,3-d pyrimidine-4-one-derivatives, production and use thereof |
| 07/02/2008 | EP1539166B1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
| 07/02/2008 | EP1333828B1 Prevention of development of dyskinesias |
| 07/02/2008 | EP1296940B1 Amidine derivatives as selective antagonists of nmda receptors |
| 07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/02/2008 | CN101213305A Regulated expression of transgenes in the central nervous system of mammals |
| 07/02/2008 | CN101213183A Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation |
| 07/02/2008 | CN101213174A Oxindole compounds and their uses as therapeutic agents |
| 07/02/2008 | CN101210051A Anti-VEGF antibodies |
| 07/02/2008 | CN101210050A Anti-vegf antibodies |
| 07/02/2008 | CN101210016A Heterocycle-fused morphinans compounds, preparation method and use thereof |
| 07/02/2008 | CN101210012A Novel isoflavone nicotinic acid ester derivatives, preparing method and use thereof |
| 07/02/2008 | CN101209994A Selectivity M4 acceptor antagonist and medical use thereof |
| 07/02/2008 | CN101209993A Medical use for levorotatory phencynonate as nerve protecting agent |
| 07/02/2008 | CN101209976A Substituted tartaric acid derivatives and use thereof for preparing beta-secretase inhibitor |
| 07/02/2008 | CN101209323A Compound essential oil capable of improving sleeping |
| 07/02/2008 | CN101209314A Drup-dropping medicine and preparation thereof |
| 07/02/2008 | CN101209302A Heat-clearing and detoxication traditional Chinese medicine preparation and preparation thereof |
| 07/02/2008 | CN101209292A Medicinal liquor for treating trigeminal neuralgia |
| 07/02/2008 | CN101209289A Tranquilizing effect of polygala total flavone |
| 07/02/2008 | CN101209288A Corydalis decumbentis orally disintegrating tablets |
| 07/02/2008 | CN101209272A Panax ginseng super powder effervescent tablets and preparation thereof |
| 07/02/2008 | CN101209266A Compound sobering-up agent |
| 07/02/2008 | CN101209253A Aripiprazole dropping pill and preparation thereof |
| 07/02/2008 | CN101209171A Pillow containing tea, carbon and Chinese herbal medicine composite granules and preparation method thereof |
| 07/02/2008 | CN101209124A Fruit ganoderma lucidum health care beverage and preparation thereof |
| 07/02/2008 | CN101209108A Food containing theanine |
| 07/02/2008 | CN101209096A Edible porridge and preparation method thereof |
| 07/02/2008 | CN100398653C Novel streptococcus antigens |
| 07/02/2008 | CN100398541C Pyrimidinone derivatives and 3-keto ester |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398524C Tetrahydroquinazolines and dihydrocyclopentapyrimidines as CFR antagonists |
| 07/02/2008 | CN100398521C 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 07/02/2008 | CN100398506C 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 07/02/2008 | CN100398154C Remedies for psychoneurosis |
| 07/02/2008 | CN100398152C Novel human beta 2 integrin alpha subunit |
| 07/02/2008 | CN100398138C Chinese medicine for against depressive disorders and hypothermia |
| 07/02/2008 | CN100398120C Full Chinese medicine oral liquid for improving eyesight |
| 07/02/2008 | CN100398119C Medicine for improving sleep quality and its preparation method |
| 07/02/2008 | CN100398113C Nano selenium of Melatonin and its preparation method |
| 07/02/2008 | CN100398110C Preparation containing ultra-low-doses of estrogen, patch and reagent box |
| 07/02/2008 | CN100398103C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/02/2008 | CN100398098C Ganoderma astragalus drip pill for treating heart spleen vacuity |
| 07/02/2008 | CN100398093C Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 07/02/2008 | CN100398012C Health-care food for anti oxidation and improving sleep |
| 07/01/2008 | US7393925 structural modification alters the biological persistence, preferably the biological half-life |
| 07/01/2008 | US7393872 Sodium channel blocker compositions and the use thereof |
| 07/01/2008 | US7393859 Amide substituted imidazoquinolines |
| 07/01/2008 | US7393858 Tetrahydropyran compounds as tachykinin antagonists |
| 07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
| 07/01/2008 | US7393845 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 07/01/2008 | US7393842 Pyrazole analogs acting on cannabinoid receptors |
| 07/01/2008 | US7393835 Peptide inhibitors of protein kinase C |
| 07/01/2008 | US7393830 Prolactin induced increase in neural stem cell numbers |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 06/26/2008 | WO2008077109A1 Methods of treating alzheimer's disease |
| 06/26/2008 | WO2008077050A1 Adenosine derivatives as partial and full agonists of a1 adenosine receptors |
| 06/26/2008 | WO2008076810A2 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 06/26/2008 | WO2008076685A2 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |